Follicular Non-Hodgkin's Lymphoma

Also known as: Non-Hodgkin Lymphoma, Follicular Lymphoma / Follicular B-cell Non-Hodgkin's Lymphoma / Follicular B-cell non-Hodgkin lymphoma / Follicular non-hodgkin lymphoma / Nodular (follicular) lymphoma / Non Hodgkin's Follicular Lymphoma / Non-Hodgkin Lymphoma, Follicular (Nodular) / Follicular lymphoma, unspecified / Follicular lymphoma / Follicular lymphomas / Nodular lymphoma (disorder) / Follicular low grade B-cell lymphoma (disorder) / Nodular lymphoma / Malignant lymphoma, centroblastic-centrocytic, follicular (disorder) / Follicular lymphoma (morphologic abnormality) / Lymphoma, Follicular / Follicular non-Hodgkin's lymphoma (disorder)

DrugDrug NameDrug Description
DB00078Ibritumomab tiuxetanA monoclonal anti-CD20 antibody used to treat B-cell non-Hodgkin's lymphoma via a conjugated radioactive isotope.
DB05258Interferon alfaAn immunomodulator used to treat hepatitis B and C as well as certain types of cancer including cutaneous T-cell lymphoma and renal cell carcinoma.
DB00105Interferon alfa-2bA form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma.
DB00073RituximabA monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.
DrugDrug NamePhaseStatusCount
DB11595Atezolizumab1 / 2Completed1
DB15434Mosunetuzumab1 / 2Completed1
DB16409Tiragolumab1 / 2Completed1
DB06769Bendamustine2Terminated1
DB00188Bortezomib2Completed1
DB16741Bortezomib D-mannitol2Completed1
DB08870Brentuximab vedotin2Terminated1
DB00073Rituximab2Completed1
DB00073Rituximab2Terminated1
DB11581Venetoclax2Completed1
DB06769Bendamustine3Completed1
DB00531Cyclophosphamide3Completed1
DB00997Doxorubicin3Completed1
DB00078Ibritumomab tiuxetan3Completed1
DB00635Prednisone3Completed1
DB00073Rituximab3Completed2
DB00541Vincristine3Completed1
DB17366MB-102 CD123 CARNot AvailableEnrolling by Invitation1